NCT05003414View on ClinicalTrials.gov

The Medacta International GMK Sphere Cementless Post-Marketing Surveillance Study

Active, not recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

January 14, 2020

Primary Completion Date

January 31, 2030

Study Completion Date

December 31, 2032

Conditions
ArthritisTraumatic ArthritisRheumatoid ArthritisPoly-arthritisAvascular Necrosis
Interventions
DEVICE

GMK Sphere cementless Knee Replacement

Performance of Total Knee Arthroplasty (TKA) with GMK Sphere cementless Knee Replacement

Trial Locations (5)

14000

Clinique du Parc, Caen

38300

Clinique Saint Vincent de Paul, Bourgoin

62780

Clinique des Acacias, Cucq

68000

Hôpitaux Civils de Colmar, Colmar

CH-1217

Hôpital de la Tour, Meyrin

Sponsors
All Listed Sponsors
lead

Medacta International SA

INDUSTRY